-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Fusion Pharmaceuticals Reports Progress, Provides Corporate Highlights

Reuters · 01/06/2023 07:53
BRIEF-Fusion Pharmaceuticals Reports Progress, Provides Corporate Highlights

- Fusion Pharmaceuticals Inc FUSN.O:

  • FUSION PHARMACEUTICALS REPORTS PROGRESS AND PROVIDES RECENT CORPORATE HIGHLIGHTS

  • FUSION PHARMACEUTICALS INC - FPI-2068 IND EXPECTED TO BE SUBMITTED IN Q1 OF 2023

  • FUSION PHARMACEUTICALS INC - FPI-1434 PHASE 1 DATA EXPECTED IN Q2 OF 2023

  • FUSION PHARMACEUTICALS INC - FPI-1966 PHASE 1 STUDY OPEN AND ENROLLING PATIENTS; COMPANY EXPECTS TO PROVIDE CLINICAL DATA UPDATE IN 2024

Source text for Eikon: ID:

Further company coverage: FUSN.O


((Reuters.Briefs@thomsonreuters.com;))